These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 7249943)

  • 21. [Diabetes therapy using oral antidiabetics].
    Hasslacher C; Wahl P
    Z Allgemeinmed; 1972 Apr; 48(12):583-7. PubMed ID: 5034166
    [No Abstract]   [Full Text] [Related]  

  • 22. [Oral antidiabetics].
    Standl E
    Schwest Rev; 1975 May; 13(5):20-2. PubMed ID: 1040261
    [No Abstract]   [Full Text] [Related]  

  • 23. Mode of action of oral hypoglycemic drugs. Introductory remarks.
    Fain JN
    Fed Proc; 1977 Dec; 36(13):2712-3. PubMed ID: 336409
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anti-diabetic drugs].
    Smith SE
    Xianggang Hu Li Za Zhi; 1979 Nov; (27):24-5. PubMed ID: 397162
    [No Abstract]   [Full Text] [Related]  

  • 25. [Three-year experience with the antidiabetic glibornurid (Glutril)].
    Hammerl H; Henk W; Köhn H; Kränzl C; Pichler O; Studlar M
    Wien Med Wochenschr; 1974 Jul; 124(27):448-52. PubMed ID: 4210108
    [No Abstract]   [Full Text] [Related]  

  • 26. [Oral diabetes therapy. Possibilities and limits].
    Bachmann W
    Internist (Berl); 1981 Apr; 22(4):204-10. PubMed ID: 7014509
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diamicron].
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):343-9. PubMed ID: 4679568
    [No Abstract]   [Full Text] [Related]  

  • 28. [Gliquidon in anti-diabetic therapy of patients with kidney and liver insufficiencies].
    Büchele W; Kuhlmann H
    Med Welt; 1978 May; 29(21):897-900. PubMed ID: 651643
    [No Abstract]   [Full Text] [Related]  

  • 29. [Gliclazide, a new antidiabetic with hemobiologic and vascular properties].
    Plauchu M; Pousset G
    Lyon Med; 1972 Oct; 228(16):383-5. PubMed ID: 4637685
    [No Abstract]   [Full Text] [Related]  

  • 30. Practical therapeutics--use of oral anti-diabetic agents.
    Obel AO
    East Afr Med J; 1982 Feb; 59(2):91-5. PubMed ID: 7128503
    [No Abstract]   [Full Text] [Related]  

  • 31. [New oral hypoglycemic agent: K 4024 or glipizide. Clinical trial].
    Angeli G; Baraldi B; Tiraboschi L; Caputo G
    Clin Ter; 1972 Dec; 63(5):438-52. PubMed ID: 4566419
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of sulfanilamide preparations on the blood coagulation system in patients with diabetes mellitus].
    Vasiukova EA; Pisarskaia IV; Sharova IuA
    Ter Arkh; 1974; 46(10):53-5. PubMed ID: 4432223
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical experiences in long-term therapy of adult diabetes using glibornuride (Ro 6-4563)].
    Ewald W; Hartmann HM; Haupt E; Kunkel W; Neubauer M; Bartelt KM; Beyer J; Cordes U; Schulz F; Schöffling K
    Med Klin; 1973 Mar; 68(12):376-85. PubMed ID: 4806346
    [No Abstract]   [Full Text] [Related]  

  • 34. Update on diabetes mellitus.
    Moss JM
    Med Times; 1981 Aug; 109(8):70-3. PubMed ID: 7024704
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].
    Simonin R
    Mars Med; 1972; 109(10):655-8. PubMed ID: 4659845
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical evaluation of glidiazinamide].
    Pedrazzi F; Bommartini F
    G Gerontol; 1972 May; 20(5):459-67. PubMed ID: 4626363
    [No Abstract]   [Full Text] [Related]  

  • 37. [Peroral antidiabetics].
    Johansen K
    Ugeskr Laeger; 1982 Mar; 144(11):811-3. PubMed ID: 7101513
    [No Abstract]   [Full Text] [Related]  

  • 38. The therapeutic efficacy of rosiglitazone is enhanced in sulphonylurea-treated patients with type 2 diabetes.
    Itakura H; Abbasi F; Lamendola C; Basina M; Reaven G
    Diabetes Obes Metab; 2008 Aug; 10(8):685-7. PubMed ID: 18476981
    [No Abstract]   [Full Text] [Related]  

  • 39. The oral hypoglycaemic agents reassess.
    Drug Ther Bull; 1974 Mar; 12(5):17-20. PubMed ID: 4820614
    [No Abstract]   [Full Text] [Related]  

  • 40. [The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)].
    Masbernard A; Portal A
    Therapeutique; 1972 Nov; 48(9):569-73. PubMed ID: 4650526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.